gp33-38, an early human T cell activation antigen
- PMID: 2138192
gp33-38, an early human T cell activation antigen
Abstract
We describe an activation Ag Me14/D12 that appears early after T cell activation and is absent in resting T lymphocytes. Me14/D12 is a nondisulfide-linked heterodimeric structure containing two polypeptide chains of 33,000 and 38,000 Da. The expression of Me14/D12 on resting T lymphocytes can be induced by different activation stimuli such as the lectins PHA and Con A, the phorbol ester PMA, and anti-CD3 mAb. The induction of mRNA for Me14/D12 (gp33-38) in PHA-activated T lymphocytes precedes that of IL-2R gene transcripts by more than 20 h. Me14/D12 mRNA was detectable as early as 2 h after the onset of activation and mRNA for the IL-2R only after 24 h. The surface expression of Me14/D12 was detectable between 12 and 24 h after activation and was maximal between 24 and 48 h. Several T leukemia cell lines express the Me14/D12 Ag. On Me14/D12- cell lines, PMA and IFN-gamma induced surface expression of Me14/D12. Once Me14/D12 Ag were expressed on Jurkat cells after stimulation with either PMA or IFN-gamma, the binding of mAb Me14/D12 induced the production of significant amounts of IL-2 and of Ca2+ mobilization from internal stores. Comparative biochemical studies clearly demonstrate that Me14/D12 (gp33-38) is different from the CD69 molecular complex defined by mAb MLR3 and AIM.
Comment in
-
gp33-38, an early human T cell activation antigen.J Immunol. 1991 Mar 15;146(6):2072. J Immunol. 1991. PMID: 1672342 No abstract available.
Similar articles
-
A novel IFN-gamma regulated human melanoma associated antigen gp33-38 defined by monoclonal antibody Me14/D12. I. Identification and immunochemical characterization.J Immunol. 1988 Sep 15;141(6):2072-8. J Immunol. 1988. PMID: 3139751
-
Increased surface expression of a newly identified 150-kDa dimer early after human T lymphocyte activation.J Immunol. 1992 Jan 15;148(2):318-23. J Immunol. 1992. PMID: 1530858
-
Expression of a 33-kDa antigen Tm 1 on lymphocyte surface after modulation of cell surface antigens by IgM monoclonal antibody.J Immunol. 1988 Feb 15;140(4):1028-33. J Immunol. 1988. PMID: 2963858
-
Characterization of lymphokines mediating B cell growth and differentiation from monoclonal anti-CD3 antibody-stimulated T cells.J Immunol. 1989 Apr 1;142(7):2343-51. J Immunol. 1989. PMID: 2538506
-
Very early (VEA) and very late (VLA) activation antigens have distinct functions in T lymphocyte activation.Immunol Rev. 1989 Jun;109:153-76. doi: 10.1111/j.1600-065x.1989.tb00024.x. Immunol Rev. 1989. PMID: 2670747 Review.
Cited by
-
Suppression of blastogenesis and proliferation of activated CD4(+) T cells: intravenous immunoglobulin (IVIg) versus novel anti-human leucocyte antigen (HLA)-E monoclonal antibodies mimicking HLA-I reactivity of IVIg.Clin Exp Immunol. 2014 Oct;178(1):154-77. doi: 10.1111/cei.12391. Clin Exp Immunol. 2014. PMID: 24889882 Free PMC article.
-
Study of T-cell activation in type I diabetic patients and pre-type I diabetic subjects by cytometric analysis: antigen expression defect in vitro.J Clin Immunol. 1993 Jan;13(1):68-78. doi: 10.1007/BF00920637. J Clin Immunol. 1993. PMID: 8095271
MeSH terms
Substances
LinkOut - more resources
Miscellaneous